Abstract
We have studied the effect of RG 12525, an oral leukotriene D4 (LTD4) antagonist, on LTD4-induced bronchoconstriction in eight male subjects with mild asthma (baseline FEV1 greater than 80% predicted) in a double-blind, placebo-controlled fashion. RG 12525 800 mg displaced the dose-response curve for LTD4 to the right. The mean (95% confidence intervals) difference in log PC20FEV1 following RG 12525 and placebo was 2.88 (1.61, 4.17) doubling doses of LTD4 (P less than 0.01), a 7.5 fold difference. We conclude that RG 12525 when administered orally is an effective LTD4 antagonist in subjects with mild asthma.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barnes N., Piper P. J., Costello J. The effect of an oral leukotriene antagonist L-649,923 on histamine and leukotriene D4-induced bronchoconstriction in normal man. J Allergy Clin Immunol. 1987 May;79(5):816–821. doi: 10.1016/0091-6749(87)90215-6. [DOI] [PubMed] [Google Scholar]
- Bisgaard H., Groth S., Madsen F. Bronchial hyperreactivity to leucotriene D4 and histamine in exogenous asthma. Br Med J (Clin Res Ed) 1985 May 18;290(6480):1468–1471. doi: 10.1136/bmj.290.6480.1468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carnathan G. W., Sweeney D., Travis J., Van Inwegen R. G. The effect of RG 12525 on leukotriene D4-mediated pulmonary responses in guinea pigs. Agents Actions. 1989 Jun;27(3-4):316–318. doi: 10.1007/BF01972809. [DOI] [PubMed] [Google Scholar]
- Cloud M. L., Enas G. C., Kemp J., Platts-Mills T., Altman L. C., Townley R., Tinkelman D., King T., Jr, Middleton E., Sheffer A. L. A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma. Am Rev Respir Dis. 1989 Nov;140(5):1336–1339. doi: 10.1164/ajrccm/140.5.1336. [DOI] [PubMed] [Google Scholar]
- Israel E., Dermarkarian R., Rosenberg M., Sperling R., Taylor G., Rubin P., Drazen J. M. The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N Engl J Med. 1990 Dec 20;323(25):1740–1744. doi: 10.1056/NEJM199012203232505. [DOI] [PubMed] [Google Scholar]
- Manning P. J., Watson R. M., Margolskee D. J., Williams V. C., Schwartz J. I., O'Byrne P. M. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. N Engl J Med. 1990 Dec 20;323(25):1736–1739. doi: 10.1056/NEJM199012203232504. [DOI] [PubMed] [Google Scholar]
- Phillips G. D., Rafferty P., Robinson C., Holgate S. T. Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects. J Pharmacol Exp Ther. 1988 Aug;246(2):732–738. [PubMed] [Google Scholar]
- Smith L. J., Geller S., Ebright L., Glass M., Thyrum P. T. Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219. Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):988–992. doi: 10.1164/ajrccm/141.4_Pt_1.988. [DOI] [PubMed] [Google Scholar]
- Taylor G. W., Taylor I., Black P., Maltby N. H., Turner N., Fuller R. W., Dollery C. T. Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet. 1989 Mar 18;1(8638):584–588. doi: 10.1016/s0140-6736(89)91611-5. [DOI] [PubMed] [Google Scholar]
- Wardlaw A. J., Hay H., Cromwell O., Collins J. V., Kay A. B. Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol. 1989 Jul;84(1):19–26. doi: 10.1016/0091-6749(89)90173-5. [DOI] [PubMed] [Google Scholar]